The interim decision to upschedule codeine-containing cold and flu medicines to Schedule 4 does not make public health or economic sense, the Australian Self Medication Industry says. It says new figures reveal that upscheduling codeine-containing cold and flu medicines would cost the Australian economy $257 million annually. Costs borne by government due to increased doctor
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.